Peptide Therapy
BPC-157: BODY
PROTECTION COMPOUND
What it is, how it works, what the research shows, common dosing protocols, and how to get pharmaceutical-grade BPC-157 through a medical provider.
Medically reviewed by Missy Zammichieli, DNP, APRN, FNP-BC · Updated March 24, 2026
Book Consultation
WHAT IS BPC-157?
BPC-157 stands for Body Protection Compound-157. It's a synthetic peptide consisting of 15 amino acids, derived from a larger protective protein naturally found in human gastric juice. Researchers classify it as a "stable gastric pentadecapeptide" because of its unusual stability in the harsh acidic environment of the stomach.
BPC-157 was originally isolated and studied by Dr. Predrag Sikiric's research group at the University of Zagreb, Croatia, beginning in the early 1990s. Since then, over 100 peer-reviewed studies have been published examining its effects on tissue healing, inflammation, and organ protection.[1,8] The vast majority of this research has been conducted in animal models.
The peptide works through several mechanisms: it upregulates growth factor expression (particularly VEGF), promotes angiogenesis (the formation of new blood vessels at injury sites)[5,12], modulates the nitric oxide system, and supports the FAK-paxillin pathway, which governs cell migration to damaged tissue. The consistency of results across multiple tissue types and over 100 studies is what makes BPC-157 notable in the peptide landscape.
Unlike many compounds in the optimization world, BPC-157 isn't about performance enhancement or body composition — if body composition tracking is your goal, a DEXA scan is the right tool for that. BPC-157 is a repair molecule. The research points to a compound that helps the body heal faster and more completely from injury.
Key distinction: BPC-157 is not a steroid, not a hormone, and not a growth hormone releasing peptide. It's a signaling molecule focused on tissue repair and protection. It doesn't build muscle, alter hormone levels, or act as a performance-enhancing drug. It tells your body to repair damaged tissue more effectively.
BPC-157 BENEFITS
BPC-157 has been studied across a wide range of tissue types and injury models. The consistency of positive results across different systems is one of the compound's most compelling features.
Tendon & Ligament Healing
Accelerates repair of damaged tendons and ligaments.[4,6] Studies show increased collagen synthesis, improved tendon-to-bone healing, and faster recovery from transection injuries. This is the most well-studied application of BPC-157.
Muscle Recovery
Animal models demonstrate accelerated muscle healing after crush injuries, lacerations, and systemic damage. BPC-157 promotes muscle fiber regeneration and reduces the formation of fibrotic scar tissue during healing.
Gut Healing
Derived from a gastric protein, BPC-157 shows protective and healing effects on the GI lining. Research demonstrates benefits for inflammatory bowel conditions, NSAID-induced gut damage, leaky gut, and intestinal lesions. This is where the compound's origin story and mechanism align most directly.
Joint Health
Promotes cartilage repair and reduces joint inflammation in animal models. Studies show improved outcomes in models of osteoarthritis and joint damage, likely mediated through growth factor upregulation and anti-inflammatory pathways.
Neuroprotection
Early research suggests BPC-157 supports nerve repair and protection.[2,9] Studies show improved outcomes in models of peripheral nerve injury, traumatic brain injury, and spinal cord damage. It interacts with the dopaminergic system and appears to have neuroprotective properties.
Counteracts NSAID Damage
BPC-157 has been uniquely shown to reverse the gastrointestinal damage caused by NSAIDs (ibuprofen, naproxen, aspirin).[11] For anyone who relies on anti-inflammatories for chronic pain or recovery, this is a significant finding—addressing the side effects of the very drugs commonly used for the same conditions BPC-157 targets.
Important context: Most BPC-157 research is in animal models. Human clinical trials are limited but ongoing. The consistency of results across 100+ studies and multiple tissue types is what makes BPC-157 notable[8] — but anyone using it should understand that the human evidence base is still developing. This is a compound where the preclinical signal is strong, but the clinical confirmation is incomplete.
INTERESTED IN BPC-157?
We prescribe and monitor peptide therapy in Park Ridge, IL. Pharmaceutical-grade from a licensed 503A pharmacy.
HOW BPC-157 WORKS
BPC-157's healing effects aren't from a single mechanism. It appears to coordinate multiple repair pathways simultaneously, which may explain why it shows benefits across so many different tissue types.
Upregulates VEGF (Vascular Endothelial Growth Factor)
BPC-157 increases VEGF expression, which drives angiogenesis — the formation of new blood vessels at injury sites.[5,12] More blood vessels means more oxygen, more nutrients, and faster delivery of immune cells to damaged tissue. This is foundational to healing any injury.
Modulates the Nitric Oxide System
BPC-157 interacts with the nitric oxide (NO) pathway, producing anti-inflammatory and vasodilatory effects. It appears to normalize NO production — increasing it where needed for healing and reducing it where excess contributes to inflammation.
Activates FAK-Paxillin Pathway
The focal adhesion kinase (FAK) and paxillin signaling pathway governs cell migration and adhesion. BPC-157 activates this pathway, directing cells to migrate to injury sites and adhere to damaged tissue — essentially telling repair cells where to go and where to attach.
Promotes Collagen Synthesis
Studies show BPC-157 enhances growth hormone receptor expression in tendon fibroblasts, leading to increased collagen production.[3,10] Collagen is the structural protein in tendons, ligaments, and connective tissue — more collagen synthesis means stronger, faster structural repair.
Protects Endothelium
BPC-157 demonstrates protective effects on the vascular endothelium — the lining of blood vessels. This contributes to both its healing properties (maintaining blood supply to injured tissue) and its protective effects against various forms of organ damage.
Interacts with Dopaminergic System
Research shows BPC-157 interacts with the brain-gut axis and the dopaminergic system, which may explain its neuroprotective effects.[2,9] This connection between gut-derived peptides and neurological function is an active area of investigation.
BPC-157 DOSING & ADMINISTRATION
BPC-157 is administered as a subcutaneous injection. Here are the standard protocol parameters used in clinical practice:
Standard Dose
250-500mcg per day, administered as a subcutaneous injection. Can be injected near the injury site for localized effects or in the abdomen for systemic applications (gut healing, general recovery).
Cycle Length
Typically 4-12 weeks depending on injury severity and treatment goals. Acute injuries may respond in 4-6 weeks. Chronic conditions and gut healing protocols often run 8-12 weeks.
Injection Frequency
Once daily is the standard protocol. Some providers split the dose into two smaller injections per day (morning and evening) for sustained signaling, though once daily is most common.
Reconstitution
BPC-157 ships as a lyophilized (freeze-dried) powder. It's reconstituted with bacteriostatic water before use. Your provider will give you specific reconstitution instructions based on the concentration of your vial.
Storage
Refrigerate after reconstitution. Unreconstituted powder can be stored at room temperature. Ships overnight refrigerated. Once reconstituted, use within 30 days.
Vial Size
Standard vial: 5ml, 3mg/ml concentration, 15mg total. At 250mcg/day this lasts approximately 60 days (2 months). At 500mcg/day, approximately 30 days (1 month).
| Parameter | Value | Notes |
|---|---|---|
| Standard Dose | 250-500mcg/day | Subcutaneous injection near injury site or abdomen for systemic effects |
| Cycle Length | 4-12 weeks | Acute injuries 4-6 weeks; chronic conditions and gut healing 8-12 weeks |
| Injection Frequency | Once daily | Some providers split into two smaller doses (AM/PM) for sustained signaling |
| Reconstitution | Bacteriostatic water | Ships as lyophilized powder; provider gives concentration-specific instructions |
| Storage | Refrigerate after reconstitution | Unreconstituted powder stable at room temp; use within 30 days once reconstituted |
| Vial Size | 5ml / 15mg total (3mg/ml) | Lasts ~60 days at 250mcg/day or ~30 days at 500mcg/day |
Note: Dosing should be determined by your provider based on your specific condition, injury type, and treatment goals. The parameters above are general ranges used in clinical practice — your protocol may differ. Self-dosing based on internet forums is how people get suboptimal results or unnecessary side effects.
Never self-injected before? Most patients are surprised how easy it is. BPC-157 uses an insulin syringe with a 30-gauge needle — much thinner than a standard blood draw needle. The injection takes about 30 seconds and is virtually painless. We teach you proper technique during your first visit, and most patients are comfortable self-administering by their second dose.
BPC-157 SIDE EFFECTS & RISKS
BPC-157 has a favorable safety profile in the published research. No serious adverse events have been reported across 100+ studies. That said, here's what to know:
Common (mild): Injection site redness or irritation. This is the most frequently reported effect and typically resolves within minutes to hours. Rotating injection sites helps minimize this.
Less common: Nausea, dizziness, or headache. These are rare at standard therapeutic doses (250-500mcg/day) and when they occur, they're typically mild and transient.
Serious adverse events: None reported in published research. BPC-157 has not shown toxicity at doses far exceeding therapeutic ranges in animal studies. No organ damage, no hormonal disruption, no carcinogenic signals.
Important caveat: Side effect data comes primarily from animal studies. The limited human data available has not shown significant safety concerns, but long-term human safety data is still being established. This is an honest limitation of the current evidence base.
Patients on blood thinners — BPC-157 has demonstrated interactions with the coagulation system in animal studies. Patients taking warfarin, heparin, DOACs (direct oral anticoagulants), or high-dose aspirin should discuss potential interactions with their provider before starting BPC-157. Your provider will review your medication list during your consultation.
The biggest risk isn't BPC-157 itself — it's the source. Using unregulated "research chemical" products with unknown purity, incorrect concentrations, and potential contamination (bacterial endotoxins, heavy metals, residual solvents) introduces risks that have nothing to do with the peptide. When you inject something, what's in the vial matters more than what's on the label. More on sourcing below.
BPC-157 RESULTS: WHAT TO EXPECT
Healing isn't instantaneous. Here's a realistic timeline of what most patients experience during a BPC-157 protocol:
Week 1-2
Early Response
Reduced inflammation and pain at injection sites. Many patients notice improved mobility and less morning stiffness. Gut healing protocols may notice reduced bloating and discomfort.
Week 2-4
Building Momentum
Continued pain reduction. Improved range of motion at injury sites. Gut permeability improvements becoming noticeable.
Week 4-8
Structural Repair
Structural repair progresses. Tendon and ligament strength improving. Joint stability increasing. Gut healing protocols showing significant improvement.
Week 8-12
Full Cycle
Full cycle effects. Maximum healing benefit from the initial protocol. Provider reassesses — some patients continue, others cycle off. Long-standing chronic injuries may need additional cycles.
Individual results vary. Results depend on injury type, severity, duration, individual healing capacity, and dosing protocol. These timelines reflect typical clinical observations, not guaranteed outcomes.
NOT SURE WHICH PEPTIDE IS RIGHT?
Take our free peptide quiz and get a personalized recommendation in 2 minutes.
BPC-157 FOR SPECIFIC INJURIES
BPC-157 has been studied across multiple injury types. Here's how it applies to specific conditions:
BPC-157 for Knee Injuries
Research supports BPC-157 for patellar tendinopathy, meniscus support, ACL recovery support, and post-surgical knee rehab. Its ability to promote collagen synthesis and new blood vessel formation at the injury site makes it particularly relevant for the knee's complex connective tissue structures. For stubborn knee injuries, combining BPC-157 with shockwave therapy can address both the biological repair and the mechanical tissue remodeling simultaneously.
BPC-157 for Shoulder & Rotator Cuff
BPC-157 has been studied for rotator cuff tendinopathy, labral support, frozen shoulder, and post-surgical recovery.[6] The shoulder's rotator cuff tendons are notoriously slow to heal due to limited blood supply — BPC-157's angiogenic properties directly address this bottleneck.
BPC-157 for Achilles Tendon
Achilles tendon healing is one of BPC-157's most studied applications.[4,7] Research demonstrates accelerated repair of Achilles tendinopathy, partial tears, and post-rupture recovery support. Published studies show faster functional recovery and improved tendon strength in animal models.
BPC-157 for Tennis & Golfer's Elbow
Lateral epicondylitis (tennis elbow) and medial epicondylitis (golfer's elbow) involve chronic tendon degeneration at the elbow. BPC-157's collagen-promoting and anti-inflammatory mechanisms target the underlying tendinopathy rather than just masking pain.
BPC-157 for Gut Healing
As a compound derived from gastric juice, BPC-157 has a logical connection to gut healing. Research demonstrates benefits for IBS, leaky gut, NSAID-induced damage[11], chronic gut inflammation, and food sensitivities. It protects and repairs the intestinal lining while reducing inflammatory markers.
BPC-157 for Back & Spine
BPC-157 may support spinal ligament and soft tissue repair based on its general connective tissue healing properties. Research on intervertebral disc repair is limited — if you have a herniated disc, BPC-157 should complement evidence-based interventions (physical therapy, injections, surgery), not replace them.
BPC-157 VS TB-500
BPC-157 and TB-500 are the two most commonly used healing peptides. They work through fundamentally different mechanisms, which is why they're often combined.
| Feature | BPC-157 | TB-500 |
|---|---|---|
| Origin | Derived from human gastric juice | Derived from thymosin beta-4 (thymus gland) |
| Primary Mechanism | Angiogenesis (new blood vessel formation) and growth factor upregulation | Actin upregulation and cell migration to injury sites |
| Best For | Tendon and ligament healing, gut repair, localized injury recovery | Muscle recovery, systemic tissue repair, flexibility |
| Administration | Near injury site for localized effects | Systemic — works throughout the body regardless of injection site |
| Cost | $250/mo at Moonshot Medical | $250/mo at Moonshot Medical |
| Combined Option | Wolverine Blend — $394/mo (vs. $500 separately, saving $106) | |
Combined: The Wolverine Blend
Many providers combine BPC-157 and TB-500 for comprehensive healing — BPC-157 builds the blood supply and growth factor environment while TB-500 mobilizes repair cells to the site. At Moonshot Medical, the Wolverine Blend combines both peptides for $394/mo (vs. $500 if purchased separately, saving $106). Read the full TB-500 guide for more detail on thymosin beta-4.
WHO IS BPC-157 FOR?
BPC-157 is a targeted therapy for tissue repair and recovery. It's most appropriate for people dealing with specific injuries or conditions, not as a general wellness supplement. Before starting a protocol, we recommend baseline blood work to establish your inflammatory markers and overall health status.
Good Candidates
Athletes recovering from tendon/ligament injuries — Achilles tendonitis, rotator cuff issues, tennis elbow, patellar tendinopathy. This is BPC-157's strongest studied application.
Chronic joint pain — Persistent joint issues that haven't fully resolved with physical therapy, rest, or standard anti-inflammatory treatment.
Gut issues — IBS, leaky gut, NSAID-related GI damage, and chronic intestinal inflammation. BPC-157's gastric origin makes this a particularly logical application.
Post-surgical recovery — Accelerating healing after orthopedic surgery, soft tissue repairs, or procedures where tissue recovery is the limiting factor.
Chronic inflammation — Conditions where persistent inflammation is driving tissue damage or slowing recovery.
Who Should Avoid BPC-157
Pregnant or nursing women — Insufficient safety data in pregnancy and lactation. Standard precaution for any peptide therapy.
Active cancer patients — BPC-157 promotes angiogenesis (new blood vessel growth). In theory, this could support tumor vascularization. While no evidence links BPC-157 to cancer progression, the precautionary principle applies.
History of hormone-sensitive conditions — As a precaution, until more human data is available. Your provider will screen for contraindications.
Patients on blood thinners — BPC-157 has demonstrated interactions with the coagulation system in animal studies. Patients taking warfarin, heparin, DOACs (direct oral anticoagulants), or high-dose aspirin should discuss potential interactions with their provider before starting BPC-157. Your provider will review your medication list during your consultation.
Bottom line: BPC-157 is a precision tool for recovery, not a general performance enhancer. If you have a specific injury or gut issue that hasn't resolved with standard treatment, it's worth discussing with a provider who works with peptides.
HOW TO GET BPC-157
BPC-157 is available through 503A compounding pharmacies with a valid prescription from a licensed medical provider. Understanding the regulatory landscape helps clarify what's legal, what's not, and why sourcing matters.
Is BPC-157 FDA Approved?
No, BPC-157 is not FDA approved. No pharmaceutical company has funded the human clinical trials required for FDA approval. BPC-157 is a naturally occurring peptide fragment — it can't be strongly patented, so the economic incentive for $100M+ clinical trials doesn't exist. This doesn't mean it's unsafe — it means it hasn't gone through the specific regulatory pathway the FDA requires for approved drugs. BPC-157 is available through 503A compounding pharmacies with a valid prescription.
The 503A vs. 503B Distinction
The FDA's 2024 decision removed BPC-157 from 503B outsourcing facility eligibility. 503B facilities produce bulk quantities of compounded medications without patient-specific prescriptions. 503A compounding pharmacies operate differently — they fill individual prescriptions for specific patients, under direct provider oversight. Patient-specific 503A compounding operates under a separate regulatory framework.
How Moonshot Medical Sources BPC-157
Moonshot Medical works with a licensed 503A compounding pharmacy that provides pharmaceutical-grade BPC-157. Every batch is tested for identity, purity, potency, and sterility. This is a fundamentally different product than what you find on "research chemical" websites.
What You Get
A pharmaceutical-grade compound with verified purity and potency. A personalized dosing protocol based on your specific condition. Medical oversight throughout your treatment cycle. This is the difference between "I'm injecting something I bought online" and "I'm on a managed therapeutic protocol."
"Research chemical" websites are not the same thing. Peptides sold online as "for research purposes only" are not manufactured under pharmaceutical standards, not tested for human use, and may contain incorrect substances, wrong concentrations, or contamination. There's no quality assurance and no way to verify what you're injecting. The price might be lower, but the risk is categorically different.
If you're looking for BPC-157 near me in Park Ridge, Des Plaines, Niles, Edison Park, or the greater Chicago suburbs, Moonshot Medical provides pharmaceutical-grade BPC-157 with in-person medical oversight at 542 Busse Hwy, Park Ridge, IL.
BPC-157 COST AT MOONSHOT MEDICAL
Transparent pricing. No hidden fees. Here's what BPC-157 therapy costs at Moonshot Medical in Park Ridge, IL:
$250/mo
BPC-157 therapy — pharmaceutical-grade compound from a licensed 503A compounding pharmacy
Included
Medical oversight, personalized dosing protocol, injection training, and monitoring throughout treatment
Not Covered
Insurance does not cover peptide therapy — it's a cash-pay service at all clinics, not just ours
Protocol Pricing (save 15-20%)
Most patients see meaningful results at 6-12 weeks. We recommend a minimum 3-month protocol.
3-Month Protocol: $635
$212/mo — save $115
6-Month Protocol: $1,200
$200/mo — save $300
BPC-157 vs Alternative Treatment Costs
| Treatment | Typical Cost | Duration | Mechanism |
|---|---|---|---|
| BPC-157 at Moonshot | $250/month | 4-12 week protocol | Promotes tissue repair via angiogenesis + growth factors |
| Cortisone Injection | $150-350/shot | Temporary (weeks-months) | Reduces inflammation only — does not repair tissue |
| PRP Therapy | $500-2,000/session | 1-3 sessions | Concentrated platelets promote healing at injection site |
| Physical Therapy | $200-400/month | Ongoing | Strengthens surrounding tissue — complementary to BPC-157 |
| Orthopedic Surgery | $10,000-50,000+ | One-time + rehab | Structural repair — reserved for severe injuries |
Costs are approximate national averages. BPC-157 is not a replacement for surgery in cases of complete tears or structural failure.
An initial consultation is required before starting BPC-157 therapy. This is where we review your medical history, discuss your injury or condition, determine if BPC-157 is appropriate, and build your dosing protocol.
See our full peptide therapy services and pricing page for details on all available peptides.
BPC-157 FAQ
What is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids, derived from a protective protein found in human gastric juice. It has been studied extensively in animal models for its ability to accelerate healing of tendons, ligaments, muscle, gut lining, and nerve tissue. It works by upregulating growth factor expression, promoting angiogenesis, and modulating the nitric oxide system.
Is BPC-157 legal?
BPC-157 is not FDA-approved and was nominated for, then removed from, 503B bulk-compounding eligibility in 2024 based on FDA's safety review. Some 503A pharmacies continue to dispense patient-specific preparations of BPC-157 pursuant to a valid prescription, on the basis that 503A and 503B operate under separate statutory frameworks (FDCA §503A vs §503B). This legal position is contested and may change. Compounded BPC-157 is not an FDA-approved drug and is not equivalent to one.
How long does BPC-157 take to work?
Many patients notice improvement within 1-2 weeks, particularly reduced pain and improved mobility at injury sites. Full therapeutic effects typically develop over 4-12 weeks depending on the severity and type of injury. Gut healing applications may show results within the first 2-4 weeks.
Can I take BPC-157 orally?
Some research supports oral use of BPC-157, especially for gut healing applications—which makes sense given that it's derived from a gastric protein. However, subcutaneous injection is the standard route for systemic and musculoskeletal effects, as it provides more reliable bioavailability and allows injection near the injury site.
How much does BPC-157 cost?
At Moonshot Medical in Park Ridge, IL, BPC-157 costs $250 per month. This includes pharmaceutical-grade compound from a licensed 503A compounding pharmacy, medical oversight, a personalized dosing protocol, and monitoring. Protocol bundles are available: 3-month protocol for $635 ($212/mo, save $115) or 6-month protocol for $1,200 ($200/mo, save $300). Insurance does not cover peptide therapy.
Is BPC-157 the same as steroids?
No. BPC-157 is a signaling peptide—a short chain of amino acids that promotes tissue repair and reduces inflammation. It is not a steroid, not a hormone, and not a growth hormone releasing peptide. It works by upregulating the body's own healing mechanisms, not by introducing exogenous hormones.
Is BPC-157 safe?
BPC-157 has a favorable safety profile across 100+ published studies, primarily in animal models. No serious adverse events have been reported at therapeutic doses. The most common side effect is mild injection site irritation. However, long-term human safety data is still being established. Medical oversight ensures proper dosing and monitoring. The biggest safety risk comes from using unregulated "research chemical" products rather than pharmaceutical-grade compounds from licensed pharmacies.
Is BPC-157 FDA approved?
No. BPC-157 has not completed the FDA approval process. The FDA has noted both the lack of human clinical trial data and uncertainty about long-term safety. As a naturally occurring peptide fragment, BPC-157 also lacks strong patent protection, which has likely reduced commercial incentive to fund the trials needed for FDA approval. Patient-specific preparations dispensed through a 503A pharmacy pursuant to a valid prescription are not FDA-approved drugs.
Where can I get BPC-157?
BPC-157 is available through medical providers who work with licensed 503A compounding pharmacies. At Moonshot Medical in Park Ridge, IL, BPC-157 costs $250 per month and includes pharmaceutical-grade compound, medical oversight, personalized dosing, and monitoring. You cannot legally purchase BPC-157 for human use without a prescription.
Can BPC-157 heal tendons?
BPC-157 has been studied extensively for tendon healing. Research shows it accelerates repair of transected tendons, increases collagen synthesis, and promotes new blood vessel formation at injury sites. It has been studied specifically in Achilles tendon, rotator cuff, patellar tendon, and other tendon injury models. Most evidence is from animal studies, but the consistency of results across 100+ studies and multiple tendon types is significant.
What is the best peptide for healing?
It depends on the injury. BPC-157 is strongest for tendon, ligament, and gut healing — it works by building new blood vessels and upregulating growth factors. TB-500 is strongest for muscle recovery and systemic tissue repair — it works by mobilizing repair cells via actin upregulation. The Wolverine Blend combines both for comprehensive healing. GHK-Cu is best for skin and anti-aging. Your provider can recommend the right peptide based on your specific condition.
How do you inject BPC-157?
BPC-157 is administered as a subcutaneous injection using an insulin syringe. The injection can be given near the injury site for localized effects or in the abdomen for systemic applications like gut healing. Your provider will teach you proper injection technique during your consultation. The process takes about 30 seconds and is virtually painless.
Is BPC-157 banned in sports?
Yes. BPC-157 is on the World Anti-Doping Agency (WADA) Prohibited List under category S0 (non-approved substances). It is banned both in-competition and out-of-competition. Athletes subject to WADA, USADA, NCAA, or other anti-doping testing should not use BPC-157. If you are a competitive athlete in a tested sport, discuss this with your provider before starting any peptide therapy.
References
- 1. Sikiric P, et al. "Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract." Curr Pharm Des. 2011;17(16):1612-32.
- 2. Sikiric P, et al. "Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications." Curr Neuropharmacol. 2016;14(8):857-865.
- 3. Chang CH, et al. "BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts." Molecules. 2014;19(11):19066-77.
- 4. Staresinic M, et al. "Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth." J Orthop Res. 2003;21(6):976-83.
- 5. Seiwerth S, et al. "BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing." Curr Pharm Des. 2018;24(18):1972-1989.
- 6. Cerovecki T, et al. "Pentadecapeptide BPC 157 (PL-10) promotes tendons-to-bone healing in a rat model of rotator cuff repair." J Orthop Surg Res. 2010;5:17.
- 7. Krivic A, et al. "Achilles detachment in rat and stable gastric pentadecapeptide BPC 157 therapy." J Pharmacol Sci. 2006;100(3):203-210.
- 8. Gwyer D, et al. "Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing." Cell Tissue Res. 2019;377(2):153-159.
- 9. Vukojevic J, et al. "Pentadecapeptide BPC 157 and the central nervous system." Neural Regen Res. 2022;17(3):482-487.
- 10. Tkalcevic VI, et al. "Enhancement by PL-14736 of collagen synthesis in healing wounds." J Physiol Paris. 1997;91(3-5):173-178.
- 11. Sikiric P, et al. "Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157." Curr Pharm Des. 2013;19(1):76-83.
- 12. Perovic D, et al. "BPC 157 and standard angiogenic growth factors: effect on angiogenesis in healing." Eur J Pharmacol. 2020;882:173298.
INTERESTED IN BPC-157?
Book a consultation to find out if BPC-157 is right for your recovery goals.
Book ConsultationPrefer to talk first? Call 224-435-4280
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. BPC-157 is not FDA-approved. Results vary by individual. Always consult a qualified healthcare provider before starting any peptide therapy. No provider-patient relationship is established by viewing this content.